Eupraxia Pharmaceuticals

EPRX

----

主要股东最新
股东
Beutel Goodman & Company Ltd.	5.50%	362.79 万	0.43%	-3.86 万	2026/06/30
Robert Disbrow	5.41%	356.82 万	0.36%	+0	2025/09/30
Manchester Management Company, LLC	4.00%	263.40 万	2.20%	-119.68 万	2026/06/30
Joseph FreedmanIndependent Director	3.86%	254.47 万	0.02%	+1,805.00	2026/09/23
Affinity Asset Advisors, LLC	2.50%	165.00 万	0.07%	+6.10 万	2026/06/30
John MontalbanoIndependent Director	2.36%	155.81 万	0.02%	+2.20 万	2026/08/19
Balyasny Asset Management L.P.	2.05%	135.00 万	0.14%	+15.00	2026/06/30
Vivo Capital, LLC	2.05%	135.00 万	0.14%	+0	2026/06/30
Scotiabank Global Banking and Markets, Asset Management Division	2.04%	134.37 万	0.13%	+1,548.00	2026/06/30
PFM Health Sciences, LP	1.84%	121.07 万	0.96%	+66.98 万	2026/06/30
Great Point Partners, LLC	1.82%	120.00 万	0.12%	+0	2026/06/30
James HelliwellCEO & Director	1.60%	105.50 万	0.14%	+15.00 万	2026/06/15
Janus Henderson Group Ltd.	1.59%	104.60 万	--	+104.60 万	2026/06/30
Rubric Capital Management LP	1.32%	86.74 万	0.20%	+17.63 万	2026/06/30
Ikarian Capital, LLC	1.23%	80.97 万	0.74%	-40.50 万	2026/06/30
Alexander RothwellChief Financial Officer	1.15%	75.69 万	0.64%	-34.71 万	2026/06/15
Woodline Partners LP	1.13%	74.69 万	0.42%	+30.63 万	2026/06/30
Point72 Asset Management, L.P.	1.11%	73.03 万	0.46%	-23.73 万	2026/06/30
Columbia Management Investment Advisers, LLC	1.08%	71.10 万	0.03%	+6.20 万	2026/06/30
Redmile Group, LLC	0.93%	61.14 万	0.20%	-8.86 万	2026/06/30

全部股东